Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lowe's Companies
LOW
|
+$217M |
| 2 |
JPMorgan Chase
JPM
|
+$213M |
| 3 |
Intel
INTC
|
+$200M |
| 4 |
FISV
Fiserv Inc
FISV
|
+$184M |
| 5 |
TECD
Tech Data Corp
TECD
|
+$174M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$685M |
| 2 |
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
|
+$127M |
| 3 |
Meta Platforms (Facebook)
META
|
+$122M |
| 4 |
Merck
MRK
|
+$110M |
| 5 |
NVIDIA
NVDA
|
+$108M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 9.01% |
| 2 | Technology | 7.75% |
| 3 | Financials | 7.01% |
| 4 | Consumer Discretionary | 6.9% |
| 5 | Industrials | 6.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ZEPP
1601
Zepp Health
ZEPP
$77.7M
| $5.7M | 0.01% |
115,339
+58,930
| +104% | +$2.72M |
|
|
ADVM
1602
DELISTED
Adverum Biotechnologies
ADVM
| $5.7M | 0.01% |
27,296
-10,505
| -28% | -$1.86M |
|
1603
Aramark
ARMK
$15.7B
| $5.7M | 0.01% |
349,505
+332,737
| +1,984% | +$5.84M |
|
1604
PUT
Deere & Co
DE
$171B
| $5.69M | 0.01% |
36,200
-15,800
| -30% | -$2.29M |
|
1605
Regenxbio
RGNX
$619M
| $5.68M | 0.01% |
+154,344
| New | +$5.75M |
|
|
CMD
1606
DELISTED
Cantel Medical Corporation
CMD
| $5.68M | 0.01% |
128,433
-561,313
| -81% | -$20.9M |
|
|
PARA
1607
DELISTED
Paramount Global Class B
PARA
| $5.67M | 0.01% |
243,227
+131,802
| +118% | +$2.54M |
|
1608
Forward Air
FWRD
$596M
| $5.67M | 0.01% |
113,739
-131,427
| -54% | -$6.45M |
|
1609
Advanced Energy
AEIS
$11.3B
| $5.66M | 0.01% |
+83,531
| New | +$4.98M |
|
1610
Kiniksa Pharmaceuticals
KNSA
$6.14B
| $5.66M | 0.01% |
222,246
+42,617
| +24% | +$890K |
|
1611
CTS Corp
CTS
$1.63B
| $5.65M | 0.01% |
282,157
+64,218
| +29% | +$1.38M |
|
1612
Williams-Sonoma
WSM
$28B
| $5.65M | 0.01% |
+137,892
| New | +$4.69M |
|
|
DOYU
1613
DouYu International Holdings
DOYU
$132M
| $5.65M | 0.01% |
48,952
+47,710
| +3,841% | +$3.98M |
|
1614
Hudbay
HBM
$13.3B
| $5.64M | 0.01% |
1,862,305
+486,843
| +35% | +$1.22M |
|
1615
Maximus
MMS
$3.09B
| $5.64M | 0.01% |
80,106
+69,685
| +669% | +$4.69M |
|
1616
John Wiley & Sons Class A
WLY
$2.7B
| $5.64M | 0.01% |
144,509
-57,401
| -28% | -$2.19M |
|
1617
RH
RH
$2.81B
| $5.63M | 0.01% |
22,633
+8,639
| +62% | +$1.57M |
|
1618
ArcelorMittal
MT
$56.2B
| $5.63M | 0.01% |
524,452
+380,490
| +264% | +$3.84M |
|
1619
PUT
McKesson
MCK
$105B
| $5.62M | 0.01% |
+36,600
| New | +$5.29M |
|
1620
Designer Brands
DBI
$290M
| $5.61M | 0.01% |
828,806
+347,786
| +72% | +$2.1M |
|
1621
Axcelis
ACLS
$3.72B
| $5.6M | 0.01% |
201,213
+184,529
| +1,106% | +$4.5M |
|
1622
Comfort Systems
FIX
$56.9B
| $5.6M | 0.01% |
137,468
-18,172
| -12% | -$646K |
|
1623
Celldex Therapeutics
CLDX
$3.19B
| $5.6M | 0.01% |
+430,564
| New | +$1.91M |
|
1624
Ormat Technologies
ORA
$6.36B
| $5.6M | 0.01% |
+88,144
| New | +$5.77M |
|
1625
Brown & Brown
BRO
$24.4B
| $5.59M | 0.01% |
137,227
-151,734
| -53% | -$5.85M |
|
Similar funds
Israel Englander's Q2 2020 Portfolio in Review
As of Q2 2020, Israel Englander held 4,914 positions worth $73B, up 64% from $44.5B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Israel Englander deployed $17.6B of net new capital in Q2 2020, opening 1,140 new positions and adding to 1,565 existing holdings. Its largest new stake was Global Payments: 1,008,446 shares worth $171M.
By sector, the portfolio is most concentrated in Healthcare at 9% of assets, down from 12% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was iShares 1-5 Year Investment Grade Corporate Bond ETF, an estimated $127M trimmed.
- Israel Englander's largest Q2 2020 buy was Global Payments: 1,008,446 shares worth $171M.
- Israel Englander added most to Lowe's Companies in Q2 2020, an estimated $217M increase.
- Israel Englander's biggest Q2 2020 reduction was iShares 1-5 Year Investment Grade Corporate Bond ETF, cutting an estimated $127M.
- Israel Englander fully exited Allergan plc in Q2 2020, selling an estimated $685M.
- Israel Englander's ten largest holdings make up 20% of its $73B portfolio in Q2 2020.
- Israel Englander opened 1,140 new positions and closed 798 in Q2 2020.
- Israel Englander's portfolio value rose 64% quarter-over-quarter to $73B.
Based on Millennium Management's 13F filing for Q2 2020, filed 14 Aug 2020.